photo of Dr Ryan Toh

Dr Ryan Toh

Dr Ryan Toh

Details

Role Senior Research Officer

Contact

Dr Ryan Toh completed his PhD in the Department of Paediatrics at the University of Melbourne in 2017. He started his role as a Research Officer in the New Vaccines Research Group in 2018 under the supervision of Professor Kim Mulholland and Associate Professor Paul Licciardi.

Ryan's research interests include exploring alternative human papillomavirus (HPV) vaccination strategies such as reduced-dose schedule and targeted vaccination of high-risk groups, to improve vaccine uptake in resource-limited settings. He has been involved in several vaccine clinical trials and has acquired considerable experience in several microbiological and immunological techniques. He has presented at numerous scientific meetings and published more than 40 manuscripts and book chapters.
Dr Ryan Toh completed his PhD in the Department of Paediatrics at the University of Melbourne in 2017. He started his role as a Research Officer in the New Vaccines Research Group in 2018 under the supervision of Professor Kim Mulholland and Associate...
Dr Ryan Toh completed his PhD in the Department of Paediatrics at the University of Melbourne in 2017. He started his role as a Research Officer in the New Vaccines Research Group in 2018 under the supervision of Professor Kim Mulholland and Associate Professor Paul Licciardi.

Ryan's research interests include exploring alternative human papillomavirus (HPV) vaccination strategies such as reduced-dose schedule and targeted vaccination of high-risk groups, to improve vaccine uptake in resource-limited settings. He has been involved in several vaccine clinical trials and has acquired considerable experience in several microbiological and immunological techniques. He has presented at numerous scientific meetings and published more than 40 manuscripts and book chapters.

Top Publications

  • Mazarakis, N, Toh, ZQ, Neal, E, Nguyen, C, Bright, K, Luu, S, Quah, L, Ng, YY, Hart, J, Do, LAH, et al. Immunogenicity and efficacy over 12 months following a fourth dose of a bivalent mRNA or protein-based COVID-19 vaccine: A randomised controlled trial in Australia.. J Infect 106727 2026
    view publication
  • Ong, DS, Toh, ZQ, Temple, B, Nguyen, CD, Phan, TV, Dai, VTT, Balloch, A, Higgins, RA, Ortika, BD, Beissbarth, J, et al. Serotype-specific immunity and association with pneumococcal carriage following 3+1, 3+0 and 2+1 schedules of 10-valent pneumococcal conjugate vaccine.. J Infect Dis 2026
    view publication
  • Van Nguyen, T, Tuan, LA, Mai, CTN, Ly, LTK, Lien, THM, Chung, NT, Huyen, DTT, Uyen, NTT, Thanh, NTT, Nhung, TTH, et al. Immunogenicity of HPV Vaccine in a High-Risk and Understudied Group: Female Sex Workers.. J Infect Dis 2026
    view publication
  • Toh, ZQ, Ma, YY, Temple, B, Anderson, J, Far, HH, Phan, TV, Dai, VTT, Huu, TN, Toan, NT, Bright, K, et al. Relationship between IL-17_A and pneumococcal carriage in children aged under two years: data from a randomised controlled trial in Vietnam.. Cytokine 198: 157094 2026
    view publication
  • Tosif, S, Neeland, M, Sutton, P, Licciardi, P, Sarkar, S, Selva, K, Do, LAH, Donato, C, Toh, ZQ, Higgins, R, et al. Immune responses to SARS-CoV-2 in children of parents with symptomatic COVID-19. 2026
    view publication

Page 1 of 19

Career information